Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2506PO in Parkinson's Disease
NCT00212693Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of arundic acid in Parkinson's disease (PD), sponsored by Ono Pharmaceutical. Started Jan 2004; status: completed.
02
Drugs
arundic acid
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00212693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212693.